𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Assessing the value of identifying the presence of malignant disease in human plasma by proton nuclear magnetic resonance spectroscopy

✍ Scribed by Steven D. Buchthal; Mark A. Hardy; Truman R. Brown

Book ID
117014866
Publisher
Elsevier Science
Year
1988
Tongue
English
Weight
597 KB
Volume
85
Category
Article
ISSN
1555-7162

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Use of proton nuclear magnetic resonance
Use of proton nuclear magnetic resonance spectroscopy of plasma in screening for malignant disease
✍ Shigeki Ono; Fuminori Moriyasu; Motoshige Nabeshima; Kozo Kajimura; Yukitaka Yam πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 707 KB

In 1986, narrow plasma proton nuclear magnetic resonance (NMR) methyl and methylene line widths were reported to be associated with malignant disease, but more recent studies have not confirmed this relationship. The authors analyzed 106 plasma samples from healthy control subjects and patients with

Proton magnetic resonance spectroscopy o
Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease
✍ Douglas L. Arnold; Paul M. Matthews; Gordon Francis; Jack Antel πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 299 KB πŸ‘ 1 views

## Abstract Image localized, water‐suppressed proton magnetic resonance spectra were obtained from affected brain in patients with multiple sclerosis. In patients with moderate to severe chronic disease, spectra revealed a decreased ratio of __N__‐acetylaspartate to creatine resonance intensities.